<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1597</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>ANTIEPILEPTICS AND PREGNANCY: A REVIEW&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Sanjay</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mohanty</surname><given-names>Biswa Bhusan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Agrawal</surname><given-names>Divya</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nayak</surname><given-names>Pramila</given-names></name></contrib><contrib contrib-type="author"><name><surname>Patnaik</surname><given-names>Shantilata</given-names></name></contrib><contrib contrib-type="author"><name><surname>Patnaik</surname><given-names>Jyotsna</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mahapatra</surname><given-names>Susanta Kumar</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>15</day><month>11</month><year>2012</year></pub-date><volume>)</volume><issue/><fpage>132</fpage><lpage>143</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Epilepsy in a pregnant woman is a serious and potentially life-threatening condition for both mother and child. Most pregnant women with epilepsy will need to take at least one antiepileptic drug. The goal for all concerned is a healthy, seizure-free mother and an undamaged child. However, epilepsy as well as antiepileptic drugs cause some serious effect on the fetus. So, for epileptic women it is important to obtain appropriate information about possibility to have children and about risks connected with their pregnancy. Every physician should be informed about risk to the fetus that is associated with seizures and drugs used for treatment during pregnancy. Drugs used in girls and young women should be chosen with the respect to the future reproduction, because the use of antiepileptic drugs (AED) in women with epilepsy is in fact a balance between seizure control and adverse effects of drugs. The purpose of this review is to provide an update on management of Women with Epilepsy (WWE) prior to and during epilepsy.&#13;
</p></abstract><kwd-group><kwd>Epilepsy</kwd><kwd> antiepileptic drugs</kwd><kwd> pregnancy</kwd><kwd> women with epilepsy (WWE)</kwd></kwd-group></article-meta></front></article>
